Chitogel Limited

Chitogel Limited is a medical device company based in Te Aro, Wellington Region, New Zealand, founded in 2014.

The company specializes in chitosan-based hydrogel nasal dressings designed for postoperative care in endoscopic sinus surgery. Chitogel develops biodegradable hydrogel products derived from natural ingredients, with its flagship product launched in 2019. The company has treated over 7,000 patients and holds FDA clearance and CE Mark certification, allowing it to expand into various international markets. The core product, the Chitogel Endoscopic Sinus Surgery Kit, is a dissolvable hydrogel dressing that helps control bleeding, reduce inflammation, and enhance wound healing after surgery. Chitogel is also working on additional products, including an Otologic Kit for middle ear surgery and solutions for laminectomy and abdominal surgery. The company is focused on growth in the US, New Zealand, Australia, and Europe, targeting healthcare professionals in otolaryngology.